Lipoic Acid: A Novel Therapeutic Approach for Multiple Sclerosis and Other Chronic Inflammatory Diseases of the CNS

E-ISSN： 2212-3873|8|2|132-142

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.8, Iss.2, 2008-06, pp. : 132-142

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Therapeutic Targets for Somatostatin in Inflammatory Chronic Diseases

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 4, Iss. 1, 2005-02 ,pp. : 91-104

Bentham Science Publishers

Access to resources Recommend Favorite

Novel therapeutic agents for multiple sclerosis

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 12, 1999-12 ,pp. : 1739-1741

Informa Healthcare

Access to resources Recommend Favorite

Lipoic Acid as a Potential Therapy for Chronic Diseases Associated with Oxidative Stress

Current Medicinal Chemistry, Vol. 11, Iss. 9, 2004-05 ,pp. : 1135-1146

Bentham Science Publishers

Access to resources Recommend Favorite

GEMSP: A New Therapeutic Approach to Multiple Sclerosis

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 12, Iss. 3, 2012-09 ,pp. : 173-181

Bentham Science Publishers

Access to resources Recommend Favorite

Ion Channel Modulation as a Therapeutic Approach in Multiple Sclerosis

Current Medicinal Chemistry, Vol. 22, Iss. 38, 2015-12 ,pp. : 4366-4378

Bentham Science Publishers

Access to resources Recommend Favorite